Abstract:Ethnopharmacological relevance This study has important ethnopharmacological implications since it systematically investigated the therapeutic potential of Bacopa monnieri (L.) Wettst. (Brahmi) in treating neurological disorders characterized by oxidative stress—a growing issue in the aging population. Bacopa monnieri , which is strongly rooted in Ayurveda, has long been recognized for its neuroprotective and cognitive advantages. The study goes beyond conventional wisdom by delving into the molecular complexities of Bacopa monnieri , particularly its active ingredient, Bacoside-A, in countering oxidative stress. The study adds to the ethnopharmacological foundation for using this herbal remedy in the context of neurodegenerative disorders by unravelling the scientific underpinnings of Bacopa monnieri 's effectiveness, particularly at the molecular level, against brain damage and related conditions influenced by oxidative stress. This dual approach, which bridges traditional wisdom and modern investigation, highlights Bacopa monnieri 's potential as a helpful natural remedy for oxidative stress-related neurological diseases. Aim of the study The aim of this study is to investigate the detailed molecular mechanism of action ( in vitro, in silico and in vivo ) of Bacopa monnieri (L.) Wettst. methanolic extract and its active compound, Bacoside-A, against oxidative stress in neurodegenerative disorders. Materials and methods ROS generation activity, mitochondrial membrane potential, calcium deposition and apoptosis were studied through DCFDA, Rhodamine-123, FURA-2 AM and AO/EtBr staining respectively. In silico study to check the effect of Bacoside-A on the Nrf-2 and Keap1 axis was performed through molecular docking study and validated experimentally through immunofluorescence co-localization study. In vivo antioxidant activity of Bacopa monnieri extract was assessed by screening the oxidative stress markers and stress-inducing hormone levels as well as through histopathological analysis of tissues. Results The key outcome of this study is that the methanolic extract of Bacopa monnieri (BME) and its active component, Bacoside-A, protect against oxidative stress in neurodegenerative diseases. At 100 μg/ml, BME and Bacoside-A quenched ROS, preserved mitochondrial membrane potential, decreased calcium deposition, and inhibited HT-22 mouse hippocampus cell death. BME and Bacoside-A regulate the Keap1 and Nrf-2 axis and their downstream antioxidant enzyme-specific genes to modify cellular antioxidant machinery. In vivo experiments utilizing rats subjected to restricted stress indicated that pre-treatment with BME (50 mg/kg) downregulated oxidative stress markers and stress-inducing hormones, and histological staining demonstrated that BME protected the neuronal cells of the Cornu Ammonis (CA1) area in the hippocampus. Conclusions Overall, the study suggests that Bacopa monnieri (L.) Wettst. has significant potential as a natural remedy for neurodegenerative disorders, and its active compounds could be developed as new drugs for the prevention and treatment of oxidative stress-related diseases.

Investigating the Neuroprotective and Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review Focused on Inflammation, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis

Pharmacological Effects of Natural Ganoderma and Its Extracts on Neurological Diseases: A Comprehensive Review

Bacopa monnieri for Disorders Affecting Brain: Current Perspectives

Bacopa monnieri as an Antioxidant Therapy to Reduce Oxidative Stress in the Aging Brain

Assessment of the mechanistic role of an Indian traditionally used ayurvedic herb Bacopa monnieri (L.) Wettst. In ameliorating oxidative stress in neuronal cells

Protective effects of Bacopa monnieri on ischemia-induced cognitive deficits in mice: the possible contribution of bacopaside I and underlying mechanism

Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation

Investigating Bacopa monnieri L. Therapeutic Potential for the Treatment of Neurological Diseases

Amelioration of Amyloid-β Induced Alzheimer's Disease by Bacopa monnieri through Modulation of Mitochondrial Dysfunction and GSK-3β/Wnt/β-Catenin Signaling

Neurocognitive effects a combined polyphenolic-rich herbal extract in healthy middle-aged adults – a randomised, double-blind, placebo-controlled study

The Safety and Efficacy of Botanicals with Nootropic Effects

Effectiveness of Bacopa Monnieri (Brahmi) in the management of schizophrenia: a systematic review

Neuroprotective role of Bacopa monnieri extract in modulating depression in an experimental rat model

Ginkgo biloba in the Aging Process: A Narrative Review

Neuroprotective effects of bacopaside I in ischemic brain injury.

Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review

Bacopaside-I ameliorates motor dysfunction and neurodegeneration in rat model of Parkinson's disease

The Neuro-Healing Frontier: Alpha-Mangostin's Potential in Alzheimer’s and Parkinson’s Treatment

Nootropic potential of Ashwagandha leaves: Beyond traditional root extracts

The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases

Effects of Scrophularia buergeriana Extract (Brainon®) on Aging-Induced Memory Impairment in SAMP8 Mice